Frontlight ResearchEarly access
Neuroendocrine tumours trials in New Zealand
2 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in New ZealandDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Grafton / Auckland
- Age
- 18 years and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Christchurch, Grafton
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244